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ABSTRACT 
Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental condition with its onset 
before the age of three years. It is characterized by abnormalities in communication, impaired 
social function, repetitive behaviours and restricted interests. There is no effective treatment 
currently available for ASD and there is a growing need of an alternative treatment modality. A 
three year six month old male patient, diagnosed with ASD was brought to the OPD for 
Ayurvedic treatment of ASD. There is no mention of ASD in Ayurveda classics and hence, 
considered an Anukta Vyadhi. ASD involves vitiation of all the three Doshas mainly Vata Dosha 
in the lead. The management was primarily based on the associated Doshas and Ayurvedic 
formulations i.e. Abhaya Ghrita orally for three months and Marsha Nasya with Panchabhautika 
Taila for forty five days were used. Changes in the clinical features were assessed using 
Aberrant Behaviour Checklist (ABC) and changes in the severity of disease after treatment was 
done using Clinical Global Impression scale (CGI). The patient showed significant improvement 
in the core features of ASD after the treatment duration. 
KEYWORDS: Autism Spectrum Disorder, Abhaya Ghrita, Panchabhautika Taila, Nasya. 
INTRODUCTION 
Autism spectrum disorder (ASD) is a group of 
heterogeneous childhood onset neurodevelopmental 
conditions characterized by social communication 
deficits, restricted interests and repetitive 
behaviors.[1] Autism spectrum disorder (ASD) is the 
term adopted by the fifth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM) 
released in May, 2013 by the American Psychiatric 
Association (APA) to encompass the previous 
diagnoses of autism, Asperger syndrome, pervasive 
developmental disorder not otherwise specified 
(PDD-NOS), and childhood disintegrative disorder. 
The clinical features of ASD fall into two categories: 
Social Interaction and Communication problems and 
Restricted and repetitive patterns of behaviors, 
interests or activities. The commonest sign and 
symptoms of ASD include absent or inconsistent eye 
contact, not responding to his/her name on being 
called, lack of social smile and social babbling, not 
playing with peers or children of same age, prefer to 
stay alone, unable to stay still for any length of time, 
flapping of hands and excess sensitivity to touch and 
sound. 
The exact cause of ASD is still under research. 
However, results from twin and family studies 
provide evidence for a strong genetic contribution, 
with multiple loci potentially involved.[2] 
Investigations of non-heritable factors suggest that 
environmental influences may also be etiologically 
important, and neuro-pathologic and biomarker 
studies provide compelling evidence for a prenatal 
origin.[3,4] Linkage studies have implicated a 
polygenic basis for autistic disorder.[5] The risk of 
ASD increases with advanced maternal and paternal 
age.[6] Moreover, although some studies suggest that 
autistic characteristics are due to central nervous 
system(CNS) dysfunction, there is evidence of 
autism-related abnormalities that are not related to 
the CNS, at least in some individuals. Hence, the 
metabolic system, immune system dysregulation and 
oxidative stress have also been implicated in the 
etiology.[7] The global prevalence of ASD has 
increased manifold in the past two decades owing to 
increased parental awareness, screening of high risk 
infants and improved diagnostic criteria. According 
to Centers for Disease Control and Prevention (CDC), 
about 1 in 59 children have been identified with 
Autism Spectrum Disorder (ASD) in United States in 
2014 as compared to 1 in 69 in 2012. Males were 
four times more likely than females to be identified 
with ASD.[8] There is currently no definite cure for 
ASD, various behavioral therapies and use of 
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pharmacological agents is currently used to manage 
the core features of ASD. However, their 
effectiveness, cost and safety are of prime concern 
among parents of ASD children.[9] 
Though there are numerous references of 
psychological disorders in Ayurveda classics, there is 
no description of exact clinical condition mimicking 
ASD. Hence, ASD can be classified as an Anukta 
Vyadhi as per Ayurveda principles and upon 
understanding its pathophysiology, management is 
made based upon involvement of Doshas, Dushya, 
Dhatu, Mala, Agni, Srotas, Adhishthana, Nidana 
Panchaka, Doshaja Prakriti, Rogi Pareeksha, Roga 
Pareeksha, and Manasa Prakriti. The clinical features 
of ASD also found resemblance with the disease 
entity Unmada mentioned in all the major Ayurveda 
classics. Upon keen consideration of etiopathogenesis 
involved in ASD, there is a need of medications and 
Panchakarma procedures which can target the higher 
centers of brain in order to manage the core features 
of ASD. Ayurveda systems of medicine possess wealth 
of single herbs, formulations and Panchakarma 
procedures that can efficiently address the ever 
increasing prevalence of ASD. 
Case Report 
A three year six months old male child was 
brought by his parents to the Kaumarabhritya OPD, 
All India Institute of Ayurveda with a diagnosis of 
Autism Spectrum Disorder (ASD). He was diagnosed 
with ASD at a Govt. Hospital, Delhi at the age of 32 
months. His chief complaints were delayed speech, 
poor eye contact, repetitive hand movements, 
increased irritability and abnormal behaviour. 
History: The patient was born at term through 
normal vaginal delivery with a birth weight of 3.4 kg. 
There was no history of fetal distress and neonatal 
jaundice or seizures. He was vaccinated as per the 
schedule. There was no history of maternal 
infections, chronic illness, fever, rashes, and use of 
medications during the pregnancy. Mother’s age at 
the time of conception was 21 year while paternal 
age was 26 year. Patient’s mother reported that as an 
infant and toddler, he was healthy and his motor 
development was within normal range for the major 
milestones of sitting, standing and walking. He was 
able to make sounds and speak few monosyllable 
words by the end of 15 months, however there was 
significant delay in communication development. At 
the age of 14 months, the mother noticed that the 
child is not paying attention to her verbal or non- 
verbal commands and was having inconsistent or 
poor eye contact with parents or family members. 
There was difficulty in responding to when being 
called by name. By the end of 24 months the parents 
started observing odd behaviour as the patient 
started making repetitive hand movements, playing 
or staying alone, not interacting with children of 
same age, hyperactivity and irritability. Despite the 
odd behavioral presentations, delayed speech was 
the major concern for which he was taken to the 
hospital at the age of 32 months. There he was 
diagnosed with ASD. He had average intellect. The 
patient took occupational and speech therapy, twice 
weekly for a period of 6 months at a Government 
Hospital, Delhi. Mild improvement in speech and 
behaviour was noticed by the parents, but therapy 
was discontinued citing economical and very slow 
improvements in the features of the patient. In need 
of an alternative, safe and economical treatment, they 
brought the child to the Kaumarabhritya OPD of All 
India Institute of Ayurveda with complaints of 
impaired understanding, impaired social interaction, 
lack of attention and concentration, increased 
hyperactivity and repetitive hand movements. 
Clinical Assessment 
During the clinical assessment, the patient 
was constantly restless, appeared disinterested and 
was easily distracted. Upon calling his name he did 
not responded. He kept making sounds and touching 
things in the examination room. He resisted physical 
touch and didn’t make eye contact while responding 
to the questions asked. He was repeating certain 
words indicating echolalia. He was able to point out 
his things of interest using verbal or non-verbal 
means. Speech was clear but was not able to speak 
full sentences. There was lack of gestures like hello, 
bye, etc., but only used them when told by his parents 
and that too was done with least interest or looking 
at the person. On neurological examination, higher 
mental functions were found impaired, while motor 
functions were intact. There was no sensory deficit 
seen. Other systemic examination was within normal 
functioning state. Personal history revealed poor 
eating habits with irregular bowel evacuation. The 
patient was found to be having Vata-Kaphaja Prakriti 
with Madhyama Sara, Satva, Samhanana and Satmya. 
His mental constitution was of Rajasika type. The 
presenting disease condition indicated vitiation of all 
the three Doshas predominantly Vata Dosha with 
involvement of Manovaha Srotas. The site of 
pathogenesis is Shirah (brain). 
Methods: The child was assessed again for the 
diagnosis of ASD using INCLEN diagnostic tool for 
Autism Spectrum Disorder (INDT-ASD).[10] The child 
fulfilled the criteria for the diagnosis of Autism. The 
severity of the disease condition was assessed using 
Clinical Global Impression (CGI) scale[11] before 
treatment and after treatment. The clinical features 
of ASD were evaluated using Aberrant Behaviour 
Checklist – Community[12] before and after treatment. 
 Praveen Kumar Sharma et al. Autism Spectrum Disorder with Abhayaghrita and Pancha Bhautika Tailanasya 
     Available online at: http://ijapr.in  19 
Management: The management of the disease 
condition was purely based on the Doshika principles 
of Ayurveda.  
Table 1: The treatment procedure adopted is shown in the table below 
S.No Name of the formulation Dose Frequency  Route of Administration Duration 
1. Abhaya Ghrita[13] 4gm Twice daily Orally before meals 90 days 
2. Panchabhautika Taila[14] 6 drops Once daily Intranasal  45 days 
Table 2: Abhaya Ghrita Composition 
S.No Ingredients Latin name Part 
1. Brahmi Bacopamonnieri (Linn.) Penn. 1 part 
2.  Siddarthak Brassica campestrisLinn.var.rapa(Linn) Hartm 1 part 
3. Kushta Saussurealappa C.B. Clarke 1 part 
4. Sariva Hemidesmusindicus R.Br 1 part 
5. Vacha Acoruscalamus Linn 1 part 
6. Pippali Piper longum Linn 1 part 
7. Saindhav Rock Salt 1 part 
8. Goghrita Cow’s Ghee 4 part 
Table 3: Panchabhautika Taila Composition 
S.No Ingredients Latin name Part 
1 Jivaka Microstylis muscifera (Lindl.) Ridl. 1  
2 Rishbaka Microstylis Wallichii Lindl 1  
3. Draksa Vitis vinifera Linn 1  
4. MadhuYasti Glycyrrhiza glabra Linn 1  
5. Pippali Piper longum Linn 1  
6 Bala Sida cordifolia Linn 1  
7. Pundarika Nelumbo nucifera Gaertn 1  
8. Brihati Solanum indicum Linn 1  
9. Manjistha Rubia cordifolia Linn 1  
10 Twak Cinnamomum zeylanicum 1  
11 Punarnava Boerhavia diffusa Linn 1  
12 Ansumati Desmodium gangeticum 1  
13 Meda⃰  Polygonatum Cirrhifolium Royle 1  
14 Vidanga Embelia ribes Burn. F. 1  
15 Nilkamala Nympho eastellate Willd 1  
16 Goksura Tribulus terrestris Linn 1  
17 Nidigdhika Solanum xanthocarpum Schrad & Wall 1  
18 Saidhava Rock salt 1  
19 Rasna Pluchea lanceolata Oliver & Hiern 1  
20 Sarkara Sugar 1  
21 Jala Water 16 part 
22 Tila Taila Sesamum indicum Linn oil 4 parts 
23  Godugdha Cow’s Milk 4 parts 
 
Int. J. Ayur. Pharma Research, 2019;7(5):17-22 
     IJAPR | May 2019 | Vol 7 | Issue 5  20 
Observations and Results: Therapeutic benefits were assessed in terms of changes in the clinical features of 
the ASD and changes in the severity of the disease at the end of the treatment duration. The patient showed 
marked improvement in the management of majority of clinical features in the five sub-scales of Aberrant 
Behaviour Checklist (ABC). The severity of disease was also found to be reduced compared to baseline 
assessment. 
Table showing changes in clinical features BT and AT using Aberrant Behaviour Checklist 
Domain BT AT 
Irritability 12 3 
Social Withdrawal 15 3 
Stereotypic behavior 14 12 
Non-compliance/ hyperactivity 6 5 
Inappropriate speech 2 1 
BT-Before Treatment, AT-After Treatment 
Table showing changes in the severity of disease using Clinical Global Impression Scale: 
Severity of Disease 
BT AT 
4 (moderately ill) 3 (mildly ill) 
The patient showed minimal improvement upon 
completion of treatment duration. 
DISCUSSION 
Autism Spectrum Disorder is an early 
emerging neurodevelopmental disorder which 
persist into adulthood with varying degree of deficits 
in social interaction and communication, and 
restricted, repetitive behaviour or interest. Multiple 
etiological factors like genetic, environmental, 
prenatal, perinatal, and postnatal events, maternal 
and paternal age, maternal infections, chronic illness 
and medications during pregnancy have been 
researched upon as possible risk factors, but definite 
cause for ASD is still not clear. A deficit in brain 
development is linked with the impaired social 
communication and repetitive, restricted behaviours 
found in ASD according to many studies.[15] Various 
regions of brain have been suggested to mediate 
clinical phenotypes of ASD such as the fronto-
temporal lobe, frontoparietal cortex, amygdala, 
hippocampus, basal ganglia, and anterior cingulate 
cortex (ACC).[16] There is no description of Autism 
found in the Ayurveda classics. It can be considered 
as an Anukta Vyadhi. Moreover Acharya Charaka 
stated that it is really difficult and not necessary to 
name every disease owing to its multifactorial 
etiology and complex pathogenesis and therefore 
with clear understanding of vitiated Doshas, Nidana 
and Vyadhi Adhisthana (site of disease 
manifestation), a physician is able to successfully 
initiate the Chikitsa Karma (management).[17] 
Balanced state of Vata Dosha is said to be the 
controller of all the motor and sensory actions in the 
body. Vata controls and coordinate the mental 
faculties. It enables proper breathing movements and 
circulation of Dhatus all over the body. [18] Due to this, 
Vata is considered to be the controller of nervous 
system in Ayurveda. The clinical features found in 
ASD are indicative of impaired higher mental 
functions due to an unknown cascade of events 
occurring in the prefrontal executive circuits, 
reticular activating system, autonomic nervous 
system, enteric nervous system, limbic system and 
hypothalamus regions of the brain. Thus treatment 
principle adopted in the present case report is the 
Shamana of the vitiated Tridosha predominantly Vata 
located in the Shirah (head) with the oral 
administration of Abhaya Ghrita and Marsha Nasya 
with Panchabhautika Taila. Abhaya Ghrita is a Lehana 
formulation described in Kashyapokta Lehadhyaya 
consisting of six herbs Viz. Brahmi (Bacopamonnieri 
(Linn.) Penn), Vacha (Achorus calamus Linn), 
Siddharthaka (Brassica campestris Linn), Kushtha 
(Saussurea lappa C.B.Clarke), Sariva (Hemidesmus 
indicus R.Br), and Pippali (Piper longum Linn). Brahmi 
is well established herb used for memory 
enhancement[19] and treating various central nervous 
system disorders. Pharmacological studies have 
shown Brahmi possesses central nervous system 
effects (memory enhancement, antidepressant, 
anxiolytic, anticonvulsant and antiparkinsonian), 
antioxidant, gastrointestinal, endocrine, anti-
microbial, anti-inflammatory, analgesic, cardio-
vascular and smooth muscle relaxant effects. Vacha 
has neuro-modulatory[20] and anticonvulsant 
effect.[21] Kushtha and Sariva possess anti-psychotic, 
anti-inflammatory and anti-oxidant effects. Pippali 
enhance the bioavailability of the active components 
along with its anti-oxidant, anti-epileptic and 
antidepressant effect,[22] anti-inflammatory, immuno-
modulation, anti-convulsant, central nervous 
stimulant, smooth muscle relaxant effects. Oral intake 
of Abhaya Ghrita protect the child from ill effects of 
Pishacha, Rakshas, Yakshas, and Matrakas (Invisible 
evil entities that can cause physical and psychological 
suffering to the child).[23] Abhaya Ghrita improves 
speech, vocabulary, language, cognitive functions, 
memory, intelligence and vision. Abhaya Ghrita is 
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predominantly Vata Kapha Shamaka owing largely to 
its Ushna Veerya and Katu Vipaka. The ingredients 
largely have Tikta, Katu, Madhura Rasa which is 
responsible for Agnideepana and Amapachana action, 
thereby maintaining optimal digestion, metabolism 
and assimilation process in the body and removing 
the toxins due to Ama Dosha. Moreover, being a 
Ghrita based formulation, it provide added 
therapeutic properties of Ghrita like Medhya, Ayu 
Vardhaka, Balavardhaka, Ojovardhaka, Vayasthapaka, 
Dhatuposhaka, and Unmada, Apasmara, Mada, 
Murcha, and Shoshanashaka properties.[24] 
It is important to have an alternate route of 
drug delivery that may target the nervous system 
directly and therefore Nasya (intranasal therapy) 
using Panchabhautika Taila was adopted in the 
present case. Intranasal delivery is emerging as a 
noninvasive option for delivering drugs to the CNS 
with minimal peripheral exposure. Additionally, this 
method facilitates the delivery of large and/or 
charged therapeutics, which fail to effectively cross 
the blood-brain barrier (BBB). Thus, for a variety of 
growth factors, hormones, neuropeptides and 
therapeutics including insulin, oxytocin, orexin, and 
even stem cells, intranasal delivery is emerging as an 
efficient method of administration, and represents a 
promising therapeutic strategy for the treatment of 
diseases with CNS involvement, such as Alzheimer’s 
disease, Parkinson’s disease, Huntington’s disease, 
depression, anxiety, autism spectrum disorders, 
seizures, drug addiction, eating disorders, and 
stroke.[25] Panchabhautika Taila is described by 
Acharya Kashyapa in Shatakalpadhyaya to be used in 
the form of nasal instillation (Nasya).[26] It contains 
twenty two ingredients. Considering the 
pharmacodynamics of the formulation, there is a 
predominance of Madhura, Tikta, Rasa, Ushna Veerya, 
Madhura Vipaka and Tridosha Shamaka properties. 
Acharya Kashyapa stated that use of Panchabhautika 
Taila increases the power of all the five Indriyas 
(sense organs). It is also used in diseases of head, 
insomnia, delirium, speech disorders, and loss of 
memory. Continuous use of Panchabhautika Taila 
increases memory, intellect and body strength and 
sense organs become perspicuous. Tila Taila is used 
as the lipid medium in this formulation. Tila Taila is 
considered as best Vata Shamaka and has 
Medhavardhaka,[27] Balya, Brimhna, Prinana, and 
Garbhasaya Sodhaka properties. Marsha Nasya (6 
drops each nostril) with Panchabhautika Taila helps 
in eliminating the aggravated Vata-Kapha Doshas 
located in the Shirah Pradesh (head) due to its Ushna 
Veerya and Tridosha Shamaka properties. 
After the completion of treatment duration, 
the patient showed significant improvement in core 
features of ASD and reduction of disease severity. 
There was no improvement seen in the repetitive 
behaviour. The present case report shows the 
efficacy of Ayurvedic treatment in the management of 
ASD with satisfactory outcomes. The results are 
encouraging considering the chronicity and non-
availability of definite treatment in the contemporary 
science. 
CONCLUSION 
ASD is a chronic condition leading to varying 
degree of functional incapacity going into adulthood. 
With no definite cause and management, it is a 
challenge to check the growing enigma of ASD. 
Parents of children with ASD are looking for safer 
and more effective mode of treatment and in this 
regard Ayurveda system of medicine can be a great 
alternative in the management of ASD. The basic 
principle of Tridosha Shamana is followed in the 
present case report and the results obtained are 
encouraging and supportive of the potential that 
Ayurveda possess in managing conditions like ASD. 
Therefore, more research is needed to establish the 
efficacy of Ayurveda treatment in ASD. 
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